{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T13:24:35Z","timestamp":1744377875023,"version":"3.38.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s00482-011-1069-5","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T17:26:56Z","timestamp":1312478816000},"page":"393-401","source":"Crossref","is-referenced-by-count":3,"title":["Neuropeptidwirkungen im trigeminalen System","Neuropeptide effects on the trigeminal system"],"prefix":"10.1007","volume":"25","author":[{"given":"K.","family":"Messlinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.M.","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,6]]},"reference":[{"key":"1069_CR1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejphar.2004.07.035","volume":"500","author":"Arulmani","year":"2004","unstructured":"Arulmani U, Maassenvandenbrink A, Villalon CM, Saxena PR (2004) Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur J Pharmacol 500:315\u2013330","journal-title":"Eur J Pharmacol"},{"key":"1069_CR2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/sj.bjp.0706461","volume":"147","author":"Brain","year":"2006","unstructured":"Brain SD, Cox HM (2006) Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol 147(Suppl 1):202\u2013211","journal-title":"Br J Pharmacol"},{"key":"1069_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(10)80017-4","volume":"583","author":"Buzzi","year":"1992","unstructured":"Buzzi MG, Dimitriadou V, Theoharides TC, Moskowitz MA (1992) 5-Hydroxytryptamine receptor agonists for the abortive treatment of vascular headaches block mast cell, endothelial and platelet activation within the rat dura mater after trigeminal stimulation. Brain Res 583:137\u2013149","journal-title":"Brain Res"},{"key":"1069_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/BF01252276","volume":"20","author":"Dimlich","year":"1991","unstructured":"Dimlich RV, Keller JT, Strauss TA, Fritts MJ (1991) Linear arrays of homogeneous mast cells in the dura mater of the rat. J Neurocytol 20:485\u2013503","journal-title":"J Neurocytol"},{"key":"1069_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.tips.2007.10.005","volume":"28","author":"Doods","year":"2007","unstructured":"Doods H, Arndt K, Rudolf K, Just S (2007) CGRP antagonists: unravelling the role of CGRP in migraine. Trends Pharmacol Sci 28:580\u2013587","journal-title":"Trends Pharmacol Sci"},{"key":"1069_CR6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0306-4522(98)00366-2","volume":"89","author":"Ebersberger","year":"1999","unstructured":"Ebersberger A, Averbeck B, Messlinger K, Reeh PW (1999) Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. Neuroscience 89:901\u2013907","journal-title":"Neuroscience"},{"key":"1069_CR7","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/jcbfm.1987.126","volume":"7","author":"Edvinsson","year":"1987","unstructured":"Edvinsson L, Ekman R, Jansen I et al (1987) Calcitonin gene-related peptide and cerebral blood vessels: distribution and vasomotor effects. J Cereb Blood Flow Metab 7:720\u2013728","journal-title":"J Cereb Blood Flow Metab"},{"key":"1069_CR8","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1046\/j.1468-2982.1995.1504272.x","volume":"15","author":"Edvinsson","year":"1995","unstructured":"Edvinsson L, Goadsby PJ (1995) Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia 15:272\u2013276","journal-title":"Cephalalgia"},{"key":"1069_CR9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0196-9781(98)00066-7","volume":"19","author":"Edvinsson","year":"1998","unstructured":"Edvinsson L, Gulbenkian S, Barroso CP et al (1998) Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility. Peptides 19:1213\u20131225","journal-title":"Peptides"},{"key":"1069_CR10","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-3565(25)24738-3","volume":"257","author":"Edwards","year":"1991","unstructured":"Edwards RM, Stack EJ, Trizna W (1991) Calcitonin gene-related peptide stimulates adenylate cyclase and relaxes intracerebral arterioles. J Pharmacol Exp Ther 257:1020\u20131024","journal-title":"J Pharmacol Exp Ther"},{"key":"1069_CR11","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1523\/JNEUROSCI.0869-05.2005","volume":"25","author":"Fischer","year":"2005","unstructured":"Fischer MJ, Koulchitsky S, Messlinger K (2005) The nonpeptide calcitonin gene-related peptide receptor antagonist BIBN4096BS lowers the activity of neurons with meningeal input in the rat spinal trigeminal nucleus. J Neurosci 25:5877\u20135883","journal-title":"J Neurosci"},{"key":"1069_CR12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/brain\/117.3.427","volume":"117","author":"Goadsby","year":"1994","unstructured":"Goadsby PJ, Edvinsson L (1994) Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 117(Pt 3):427\u2013434","journal-title":"Brain"},{"key":"1069_CR13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"1069_CR14","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1476-5381.2010.01012.x","volume":"161","author":"Gupta","year":"2010","unstructured":"Gupta S, Amrutkar DV, Mataji A et al (2010) Evidence for CGRP re-uptake in rat dura mater encephali. Br J Pharmacol 161:1885\u20131898","journal-title":"Br J Pharmacol"},{"key":"1069_CR15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/j.peptides.2004.06.007","volume":"25","author":"Hay","year":"2004","unstructured":"Hay DL, Conner AC, Howitt SG et al (2004) The pharmacology of CGRP-responsive receptors in cultured and transfected cells. Peptides 25:2019\u20132026","journal-title":"Peptides"},{"key":"1069_CR16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(08)61626-8","volume":"372","author":"Ho","year":"2008","unstructured":"Ho TW, Ferrari MD, Dodick DW et al (2008) Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial. Lancet 372:2115\u20132123","journal-title":"Lancet"},{"key":"1069_CR17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0306-3623(97)00078-5","volume":"30","author":"Holzer","year":"1998","unstructured":"Holzer P (1998) Neurogenic vasodilatation and plasma leakage in the skin. Gen Pharmacol 30:5\u201311","journal-title":"Gen Pharmacol"},{"key":"1069_CR18","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1468-2982.1996.1605310.x","volume":"16","author":"Jansen-Olesen","year":"1996","unstructured":"Jansen-Olesen I, Mortensen A, Edvinsson L (1996) Calcitonin gene-related peptide is released from capsaicin-sensitive nerve fibres and induces vasodilatation of human cerebral arteries concomitant with activation of adenylyl cyclase. Cephalalgia 16:310\u2013316","journal-title":"Cephalalgia"},{"key":"1069_CR19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/cne.903090408","volume":"309","author":"Keller","year":"1991","unstructured":"Keller JT, Marfurt CF (1991) Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 309:515\u2013534","journal-title":"J Comp Neurol"},{"key":"1069_CR20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/j.1476-5381.1995.tb13361.x","volume":"114","author":"Kurosawa","year":"1995","unstructured":"Kurosawa M, Messlinger K, Pawlak M, Schmidt RF (1995) Increase of meningeal blood flow after electrical stimulation of rat dura mater encephali: mediation by calcitonin gene-related peptide. Br J Pharmacol 114:1397\u20131402","journal-title":"Br J Pharmacol"},{"key":"1069_CR21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/cne.21607","volume":"507","author":"Lennerz","year":"2008","unstructured":"Lennerz JK, Ruhle V, Ceppa EP et al (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 507:1277\u20131299","journal-title":"J Comp Neurol"},{"key":"1069_CR22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pain.2007.03.012","volume":"130","author":"Levy","year":"2007","unstructured":"Levy D, Burstein R, Kainz V et al (2007) Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130:166\u2013176","journal-title":"Pain"},{"key":"1069_CR23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ana.20619","volume":"58","author":"Levy","year":"2005","unstructured":"Levy D, Burstein R, Strassman AM (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 58:698\u2013705","journal-title":"Ann Neurol"},{"key":"1069_CR24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1113\/jphysiol.2001.013175","volume":"538","author":"Levy","year":"2002","unstructured":"Levy D, Strassman AM (2002) Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors. J Physiol 538:483\u2013493","journal-title":"J Physiol"},{"key":"1069_CR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2007.12.028","volume":"1196","author":"Li","year":"2008","unstructured":"Li J, Vause CV, Durham PL (2008) Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells. Brain Res 1196:22\u201332","journal-title":"Brain Res"},{"key":"1069_CR26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1517\/13543784.10.4.673","volume":"10","author":"May","year":"2001","unstructured":"May A, Goadsby PJ (2001) Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs 10:673\u2013678","journal-title":"Expert Opin Investig Drugs"},{"key":"1069_CR27","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1523\/JNEUROSCI.5490-08.2009","volume":"29","author":"Meng","year":"2009","unstructured":"Meng J, Ovsepian SV, Wang J et al (2009) Activation of TRPV1 mediates calcitonin gene-related peptide release, which excites trigeminal sensory neurons and is attenuated by a retargeted botulinum toxin with anti-nociceptive potential. J Neurosci 29:4981\u20134992","journal-title":"J Neurosci"},{"key":"1069_CR28","first-page":"219","volume":"Embryol","author":"Messlinger","year":"1993","unstructured":"Messlinger K, Hanesch U, Baumgartel M et al (1993) Innervation of the dura mater encephali of cat and rat: ultrastructure and calcitonin gene-related peptide-like and substance P-like immunoreactivity. Anat Embryol (Berl) 188:219\u2013237","journal-title":"Anat"},{"key":"1069_CR29","first-page":"16","volume":"43","author":"Moskowitz","year":"1993","unstructured":"Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43:16\u201320","journal-title":"Neurology"},{"key":"1069_CR30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0014-2999(93)90879-M","volume":"238","author":"Moussaoui","year":"1993","unstructured":"Moussaoui SM, Philippe L, Le Prado N, Garret C (1993) Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580. Eur J Pharmacol 238:421\u2013424","journal-title":"Eur J Pharmacol"},{"key":"1069_CR31","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pain.2005.04.002","volume":"116","author":"Natura","year":"2005","unstructured":"Natura G, Banchet GS von, Schaible HG (2005) Calcitonin gene-related peptide enhances TTX-resistant sodium currents in cultured dorsal root ganglion neurons from adult rats. Pain 116:194\u2013204","journal-title":"Pain"},{"key":"1069_CR32","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1124\/pr.54.2.233","volume":"54","author":"Poyner","year":"2002","unstructured":"Poyner DR, Sexton PM, Marshall I et al (2002) International Union of Pharmacology. XXXII.\u00a0The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 54:233\u2013246","journal-title":"Pharmacol Rev"},{"key":"1069_CR33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archsurg.1940.01210040002001","volume":"41","author":"Ray","year":"1940","unstructured":"Ray BS, Wolff HG (1940) Experimental studies on headache: pain-sensitive structures of the head and their significance in headache. Arch Surg 41:813\u2013856","journal-title":"Arch Surg"},{"key":"1069_CR34","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-2982.2007.01321.x","volume":"27","author":"Schwenger","year":"2007","unstructured":"Schwenger N, Dux M, De Col R et al (2007) Interaction of calcitonin gene-related peptide, nitric oxide and histamine release in neurogenic blood flow and afferent activation in the rat cranial dura mater. Cephalalgia 27:481\u2013491","journal-title":"Cephalalgia"},{"key":"1069_CR35","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1093\/brain\/awp168","volume":"132","author":"Sixt","year":"2009","unstructured":"Sixt ML, Messlinger K, Fischer MJ (2009) Calcitonin gene-related peptide receptor antagonist olcegepant acts in the spinal trigeminal nucleus. Brain 132:3134\u20133141","journal-title":"Brain"},{"key":"1069_CR36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/sj.bjp.0705807","volume":"142","author":"Storer","year":"2004","unstructured":"Storer RJ, Akerman S, Goadsby PJ (2004) Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 142:1171\u20131181","journal-title":"Br J Pharmacol"},{"key":"1069_CR37","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/0333102411398403","volume":"31","author":"Tfelt-Hansen","year":"2011","unstructured":"Tfelt-Hansen P, Olesen J (2011) Possible site of action of CGRP antagonists in migraine. Cephalalgia 31:748\u2013750","journal-title":"Cephalalgia"},{"key":"1069_CR38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2007.01.058","volume":"562","author":"Troltzsch","year":"2007","unstructured":"Troltzsch M, Denekas T, Messlinger K (2007) The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow. Eur J Pharmacol 562:103\u2013110","journal-title":"Eur J Pharmacol"},{"key":"1069_CR39","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1468-2982.1997.1704518.x","volume":"17","author":"Williamson","year":"1997","unstructured":"Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL (1997) Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural vessel diameter in the anaesthetized rat. Cephalalgia 17:518\u2013524","journal-title":"Cephalalgia"},{"key":"1069_CR40","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1523\/JNEUROSCI.4542-06.2007","volume":"27","author":"Zhang","year":"2007","unstructured":"Zhang Z, Winborn CS, Marquez de PB, Russo AF (2007) Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion. J Neurosci 27:2693\u20132703","journal-title":"J Neurosci"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-011-1069-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-011-1069-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-011-1069-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:39:53Z","timestamp":1741412393000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-011-1069-5"}},"subtitle":["Pathophysiologie und klinische Bedeutung bei der Migr\u00e4ne","Pathophysiology and clinical significance for migraine"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1069"],"URL":"https:\/\/doi.org\/10.1007\/s00482-011-1069-5","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"type":"print","value":"0932-433X"},{"type":"electronic","value":"1432-2129"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}